Back Again to the Future: A New Era for Cerebroprotection
Cerebroprotection is a fresh framework for designing neurological therapy that targets glia and vascular cells, in addition to neurons. In the future, successful cerebroprotection will involve targeting all elements of the neurovascular unit. Preclinical trials must include functional outcomes, as well as lesion morphometry.
Patrick Lyden
wiley +1 more source
Fusion 3-Categories for Duality Defects. [PDF]
Bhardwaj L +3 more
europepmc +1 more source
Innovative Approach to Hydrogen Purification: A Review on the Role of Metal Hydrides
ABSTRACT Metal hydrides, renowned for their unique hydrogen bonding capabilities, have emerged as pivotal materials in the energy sector, particularly for hydrogen storage and purification applications. Their ability to store hydrogen reversibly under moderate conditions has positioned them at the forefront in hydrogen‐based energy systems. This review
T. Mohammed Faheem +4 more
wiley +1 more source
LoRaCELL-Driven IoT Smart Lighting Systems: Sustainability in Urban Infrastructure. [PDF]
Biundini IZ +6 more
europepmc +1 more source
ON LEFT α-MULTIPLIERS AND COMMUTATIVITY OF SEMIPRIME RINGS
Shakir Ali, S. Huang
semanticscholar +1 more source
Disparity of turbinal bones in placental mammals
Abstract Turbinals are key bony elements of the mammalian nasal cavity, involved in heat and moisture conservation as well as olfaction. While turbinals are well known in some groups, their diversity is poorly understood at the scale of placental mammals, which span 21 orders.
Quentin Martinez +11 more
wiley +1 more source
Challenges of drilling Iran's deepest surface hole in the saddle section of Changuleh oilfield with complex structure and pressure regimes. [PDF]
Jamshidi E +5 more
europepmc +1 more source
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane +33 more
wiley +1 more source
A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus
Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen +14 more
wiley +1 more source
Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?
Objective Lupus nephritis (LN) is characterized by a variable disease course, necessitating continuous monitoring. There is an urgent need to identify noninvasive biomarkers. By reviewing and critically assessing the quality of existing studies on LN biomarkers correlating with histopathology, we here explore the challenges in promoting their use in ...
Valentina Querin +11 more
wiley +1 more source

